Stock Scorecard
Stock Summary for Biocryst Pharmaceuticals Inc (BCRX) - $8.94 as of 7/3/2025 8:55:16 PM EST
Total Score
7 out of 30
Safety Score
35 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for BCRX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BCRX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BCRX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for BCRX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for BCRX (35 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 5 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for BCRX
Financial Details for BCRX
Company Overview |
|
|---|---|
| Ticker | BCRX |
| Company Name | Biocryst Pharmaceuticals Inc |
| Country | USA |
| Description | BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina. |
| Sector Name | LIFE SCIENCES |
| Industry Name | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 7/31/2025 |
Stock Price History |
|
| Last Day Price | 8.94 |
| Price 4 Years Ago | 13.85 |
| Last Day Price Updated | 7/3/2025 8:55:16 PM EST |
| Last Day Volume | 1,407,127 |
| Average Daily Volume | 3,712,532 |
| 52-Week High | 11.31 |
| 52-Week Low | 6.01 |
| Last Price to 52 Week Low | 48.75% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 58.65 |
| Sector PE | 40.90 |
| 5-Year Average PE | 20.88 |
| Free Cash Flow Ratio | 17.88 |
| Industry Free Cash Flow Ratio | 19.40 |
| Sector Free Cash Flow Ratio | 32.91 |
| Current Ratio Most Recent Quarter | 2.92 |
| Total Cash Per Share | 0.50 |
| Book Value Per Share Most Recent Quarter | -2.16 |
| Price to Book Ratio | 56.59 |
| Industry Price to Book Ratio | 18.75 |
| Sector Price to Book Ratio | 30.76 |
| Price to Sales Ratio Twelve Trailing Months | 3.75 |
| Industry Price to Sales Ratio Twelve Trailing Months | 48.40 |
| Sector Price to Sales Ratio Twelve Trailing Months | 35.60 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 209,250,000 |
| Market Capitalization | 1,870,695,000 |
| Institutional Ownership | 85.56% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.71% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 60.77% |
| Reported EPS 12 Trailing Months | -0.26 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -0.43 |
| Net Income Twelve Trailing Months | -53,470,000 |
| Net Income Past Year | -88,881,000 |
| Net Income Prior Year | -226,539,000 |
| Quarterly Revenue Growth YOY | 56.90% |
| 5-Year Revenue Growth | 55.97% |
| Operating Margin Twelve Trailing Months | 14.60% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 105,190,000 |
| Total Cash Past Year | 104,713,000 |
| Total Cash Prior Year | 110,643,000 |
| Net Cash Position Most Recent Quarter | -676,836,000 |
| Net Cash Position Past Year | -691,209,000 |
| Long Term Debt Past Year | 795,922,000 |
| Long Term Debt Prior Year | 811,265,000 |
| Total Debt Most Recent Quarter | 782,026,000 |
| Equity to Debt Ratio Past Year | -1.49 |
| Equity to Debt Ratio Most Recent Quarter | -1.37 |
| Total Stockholder Equity Past Year | -475,934,000 |
| Total Stockholder Equity Prior Year | -455,528,000 |
| Total Stockholder Equity Most Recent Quarter | -451,927,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -26,885,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.13 |
| Free Cash Flow Past Year | -53,144,000 |
| Free Cash Flow Prior Year | -97,309,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.27 |
| MACD Signal | -0.07 |
| 20-Day Bollinger Lower Band | 6.34 |
| 20-Day Bollinger Middle Band | 8.94 |
| 20-Day Bollinger Upper Band | 11.54 |
| Beta | 1.10 |
| RSI | 34.06 |
| 50-Day SMA | 8.22 |
| 150-Day SMA | 8.15 |
| 200-Day SMA | 9.38 |
System |
|
| Modified | 7/4/2025 2:01:59 AM EST |